查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1831920

2025-2033年核医设备市场报告（按产品、应用、最终用户和地区）

Nuclear Medicine Equipment Market Report by Product, Application, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球核医设备市场规模达33亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到54亿美元，2025-2033年期间的复合年增长率（CAGR）为5.56%。由于对慢性病治疗和早期诊断的需求日益增长，该市场正在经历显着增长。此外，影像技术的创新以及医疗保健领域（尤其是新兴和已开发地区在肿瘤学和神经病学应用方面的投资不断增加）正在进一步扩大市场规模。

核子医学设备市场趋势：

混合成像系统的采用日益增多

全球核子设备市场的一个显着趋势是，SPECT 和 PET 等混合影像解决方案的应用日益广泛。根据产业报告，2024 年 2 月，印度 PGIMER 公司开发了一种基于 PET/CT 的尖端活检技术，前列腺癌诊断的成功率高达 95%。此类先进技术融合了解剖成像和功能成像，提高了心血管疾病和癌症等复杂疾病的诊断精度。此外，此类系统的引入使医护人员能够更好地监测病情进展，从而製定更有效的治疗策略。此外，这种对混合系统的青睐凸显了对升级诊断工具日益增长的需求，从而刺激了市场成长，并促进了影像技术的进一步研发活动。

提高分子影像的利用率

根据核医设备市场研究报告，分子影像在全球市场正迅速发展。这一趋势主要得益于该技术能够提供分子和细胞活动的详细分析，这有助于早期疾病检测，尤其是在心臟病学、肿瘤学和神经病学领域。此外，分子影像技术能够实现更准确的诊断，并支持整体的个人化治疗方法。例如，2024 年 2 月，北美放射学会的研究人员开发了一种分子影像技术，该技术对乳癌检测具有高灵敏度，并降低了假阳性结果的可能性，即假阳性率为 16%，而 MRI 为 62%。此外，随着研究不断提高此类程序中使用的放射性药物的效率，对分子成像的需求预计将飙升，使其成为市场中的关键趋势。

放射性药物的采用率提高。

根据核医设备市场报告，放射性药物的广泛应用是全球市场的主要趋势之一。放射性药物在治疗和诊断应用中发挥着至关重要的作用，尤其对于某些慢性疾病和癌症。此外，放射性药物开发的创新，例如降低副作用和增强标靶剂，正在提高核子治疗和影像的疗效。此外，医疗保健提供者目前依赖此类化合物进行治疗和诊断程序，这反过来又推动了对能够有效利用此类先进药物的核医学设备的需求。例如，2024年8月，领先的製药公司礼来公司（Eli Lily）宣布其在核同位素生产行业的扩张，以确保放射性肿瘤药物所需的放射性化合物的稳定供应。作为扩张策略，该公司向同位素供应商Ionetix投资了1000万美元。

核子医学设备市场细分：

按产品分类：

  • 单光子发射电脑断层扫描
    • 独立
    • 杂交种
  • 正子断层扫描
    • 独立
    • 杂交种
  • 平面闪烁扫描

单光子发射电脑断层扫描占据大部分市场份额

根据核医设备市场预测，单光子发射电脑断层扫描 (SPECT) 预计将继续保持其作为最大产品细分市场的主导地位。独立 SPECT 系统提供必要的功能性影像，广泛应用于肿瘤学、心臟病学和神经病学。而混合 SPECT 系统融合了功能成像和解剖成像，透过提供更具洞察力的影像来提高诊断精度。此外，混合成像系统的快速应用，尤其是在复杂的诊断条件下，进一步刺激了市场需求。此外，混合 SPECT 系统提供的精确度极大地推动了其在新兴和已开发医疗保健市场的采用。例如，2024 年 3 月，Spectrum Dynamics Medical 宣布其全新创新数位 SPECT/CT VERITON-CT 400 已在欧洲一家癌症中心成功安装。这是一款能够有效侦测并定位体内肿瘤的混合 SPECT/CT。

按应用分类：

  • 神经病学
  • 肿瘤学
  • 心臟病学
  • 其他的

肿瘤学占产业最大份额

根据核医设备市场概况，肿瘤学占据主导地位，这主要归因于癌症治疗和诊断对 SPECT 和 PET 等核子造影技术的需求日益增长。这些系统透过精确的分子影像，有助于早期发现癌组织并观察治疗效果。此外，全球癌症发生率的上升，加上放射性药物和核子医学的进步，持续推动了对肿瘤专用影像设备的需求，使肿瘤学成为全球核子医学市场的主要成长领域。根据世界卫生组织的数据，大约五分之一的人在其一生中被诊断出患有癌症，而大约十二分之一的女性和男性死于癌症。

按最终用户分类：

  • 医院
  • 影像中心
  • 学术及研究机构
  • 其他的

医院是主要的细分市场

医院是最大的终端用户群体，对核医设备市场收入贡献巨大。作为一个拥有强大基础设施以维持先进治疗和诊断程序的医疗机构，医院迅速依赖PET和SPECT等尖端影像技术进行精准治疗和诊断。此外，将核医设备纳入医院生态系统对于提升病患照护水准和预后至关重要，尤其是在神经内科、肿瘤科和心臟科。此外，创新核成像技术的广泛应用以及对医院影像中心投资的不断增加，正在推动这一关键市场领域的成长。

按地区划分：

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

北美引领市场，占据最大核医设备市场份额

该报告还对所有主要区域市场进行了全面分析，包括北美（美国和加拿大）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告指出，北美是核子医学设备最大的区域市场。

北美已成为领先的区域市场，主要得益于其强大的医疗基础设施、早期采用尖端技术以及高昂的医疗支出。美国尤其处于领先地位，这主要是因为心血管疾病和癌症等慢性疾病的发生率很高，这大大加速了对核子影像的需求。根据美国国家癌症研究所的数据，预计到2024年，美国将新增2,001,140例癌症病例，约有611,720人将死于癌症。此外，政府对研发的投入，加上主要产业参与者的存在，进一步巩固了北美在全球核子医学设备市场的主导地位。

本报告回答的关键问题：

  • 全球核子医学设备市场迄今表现如何，未来几年将如何表现？
  • 全球核子医学设备市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球核医设备市场有何影响？
  • 主要的区域市场有哪些？
  • 哪些国家代表最具吸引力的核医设备市场？
  • 根据产品，市场是如何分類的？
  • 核子医学设备市场中最具吸引力的产品是什么？
  • 根据应用，市场是如何分類的？
  • 核子医学设备市场中最吸引人的应用是什么？
  • 根据最终用户，市场是如何分類的？
  • 核子医学设备市场中最具吸引力的最终用户是哪一个？
  • 市场的竞争结构是怎么样的？
  • 全球核子医学设备市场的主要参与者/公司有哪些？

本报告回答的关键问题：

  • 全球核子医学设备市场迄今表现如何，未来几年将如何表现？
  • 全球核子医学设备市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球核医设备市场有何影响？
  • 主要的区域市场有哪些？
  • 哪些国家代表最具吸引力的核医设备市场？
  • 根据产品，市场是如何分類的？
  • 核子医学设备市场中最具吸引力的产品是什么？
  • 根据应用，市场是如何分類的？
  • 核子医学设备市场中最吸引人的应用是什么？
  • 根据最终用户，市场是如何分類的？
  • 核子医学设备市场中最具吸引力的最终用户是哪一个？
  • 市场的竞争结构是怎么样的？
  • 全球核子医学设备市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球核子医学设备市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 单光子发射电脑断层扫描
    • 关键部分
      • 独立
      • 杂交种
  • 正子断层扫描
    • 关键部分
      • 独立
      • 杂交种
  • 平面闪烁扫描

第七章：市场区隔：依应用

  • 神经病学
  • 肿瘤学
  • 心臟病学
  • 其他的

第 8 章：市场区隔：依最终用户

  • 医院
  • 影像中心
  • 学术及研究机构
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 10 章：SWOT 分析

第 11 章：价值链分析

第 12 章：波特五力分析

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Biodex Medical Systems Inc. (Mirion Technologies Inc.)
    • Cardinal Health Inc.
    • CMR Naviscan Corporation
    • DDD-Diagnostic A/S
    • Digirad Corporation
    • General Electric Company
    • Koninklijke Philips NV
    • Mediso Ltd.
    • Neusoft Corporation
    • Siemens AG
    • SurgicEye GmbH
    • Toshiba Corporation
Product Code: SR112025A4598

The global nuclear medicine equipment market size reached USD 3.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.4 Billion by 2033, exhibiting a growth rate (CAGR) of 5.56% during 2025-2033. The market is witnessing significant growth due to the increasing need for chronic diseases treatment and early diagnosis. Moreover, innovations in imaging technologies and heightening investments in healthcare sector, especially in oncology and neurology applications across both emerging and developed region, is further expanding the market.

Nuclear Medicine Equipment Market Trends:

Increasing Adoption of Hybrid Imaging Systems

A notable trend in the global nuclear equipment market is the increasing adoption of hybrid imaging solutions such as SPECT and PET. As per industry reports, in February 2024, PGIMER, India, developed a cutting-edge PET/CT-based biopsy that exhibited 95% success rate for prostate cancer diagnosis. Such advanced technologies blend anatomical and functional imaging, offering improved precision in diagnosing complicated diseases such as cardiovascular disorders and cancer. In addition, the incorporation of such systems allows healthcare professionals to better monitor the progression of disease, resulting in a more efficient treatment strategy. Moreover, this inclination towards hybrid systems highlights the fueling demand for upgraded diagnostics tools, spurring market growth and fostering further research and development activities in imaging techniques.

Increasing Utilization Molecular Imaging

According to the nuclear medicine equipment market research report, molecular imaging is rapidly gaining momentum in the global market. This trend is primarily driven by the technology's capability to offer detailed analysis of molecular as well as cellular activity, which assists in early disease detection, especially in cardiology, oncology, and neurology. In addition, molecular imaging technologies are permitting more accurate diagnoses, supporting the overall customized treatment methods. For instance, in February 2024, researchers from the Radiological Society of North America developed a molecular imaging technology that offers high sensitivity for breast cancer detection with lowered chances of false positive results, i.e. 16% false positive rate in comparison to MRI's 62%. Moreover, as research continues to enhance the efficiency of radiopharmaceuticals leveraged in such procedures, the requirement for molecular imaging is anticipated to soar, establishing it as a critical trend in the market.

Heightened Adoption of Radiopharmaceuticals.

As per the nuclear medicine equipment market report, the amplifying adoption of radiopharmaceuticals is one of the key trends in the global market. Radiopharmaceuticals play a crucial role in therapeutic as well as diagnostic applications, especially for certain chronic disorders and cancer. Moreover, innovations in radiopharmaceutical development, such as lowered side effects and enhanced targeting agents, are improving the efficacy of nuclear therapy and imaging. In addition, healthcare providers are currently dependent of such compounds for treatment as well as diagnosis procedures, which is resultantly boosting the demand for nuclear medicine equipment that are efficient in leveraging such advanced agents. For instance, in August 2024, Eli Lily, a leading pharmaceutical company, announced its expansion in nuclear isotope production industry to secure a steady supply of radioactive compounds requisite for radiopharmaceutical oncology drugs. As an expansion strategy, the company invested USD 10 million into Ionetix, an isotope supplier.

Nuclear Medicine Equipment Market Segmentation:

Breakup by Product:

  • Single-Photon Emission Computed Tomography
    • Standalone
    • Hybrid
  • Positron Emission Tomography
    • Standalone
    • Hybrid
  • Planar Scintigraphy

Single-photon emission computed tomography accounts for the majority of the market share

According to the nuclear medicine equipment market forecast, single-photon emission computed tomography (SPECT) is anticipated to sustain its dominance as the largest product segment. Standalone SPECT systems offer essential functional imaging, broadly leveraged in oncology, cardiology, and neurology. Whereas, hybrid SPECT systems merge both functional and anatomical imaging, providing enhanced diagnostics precision by offering more insightful images. Moreover, the incorporation of hybrid imaging systems in rapidly adopted, especially in complicated diagnostics conditions, further boosting market demand. In addition, the accuracy provided by hybrid SPECT systems is significantly fueling their adoption in emerging as well as developed healthcare markets. For instance, in March 2024, Spectrum Dynamics Medical announced the successful installation of its new, innovative, digital SPECT/CT VERITON-CT 400 at a European cancer center. It is a hybrid SPECT/CT that can efficiently detect and locate tumors in the body.

Breakup by Application:

  • Neurology
  • Oncology
  • Cardiology
  • Others

Oncology holds the largest share of the industry

As per the nuclear medicine equipment market overview, oncology represents the dominant application segment, majorly due to the increasing demand for nuclear imaging technologies such as SPECT and PET in cancer treatment as well as diagnosis. Such systems facilitate the early detection of cancerous tissues and the observation of treatment efficiency through accurate molecular imaging. In addition, the heightening prevalence of cancer worldwide, combined with advancements in radiopharmaceuticals and nuclear medicine, continues to bolster the demand for oncology-specific imaging equipment, establishing oncology as a major growth segment in the global nuclear medicine market. According to the World Health Organization, around 1 in 5 individuals are detected with cancer in their lifetime, while around 1 in 12 women and 1 in men die from this disease.

Breakup by End User:

  • Hospitals
  • Imaging Centers
  • Academic and Research Institutes
  • Others

Hospitals represent the leading market segment

Hospitals are the largest end-user segment that significantly contributes to the nuclear medicine equipment market revenue. As healthcare institutions with the robust infrastructure to maintain the sophisticated therapeutic and diagnostic procedures, hospitals rapidly dependent on cutting-edge imaging technologies such as PET and SPECT for precise treatment as well as diagnosis. In addition, the incorporation of nuclear medicine equipment into hospital ecosystem is requisite for enhancing patient care and outcome, especially in neurology, oncology, and cardiology. Moreover, the magnifying adoption of innovative nuclear imaging technologies and heightening investments in hospital-based imaging centers are bolstering growth within this crucial market segment.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest nuclear medicine equipment market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for nuclear medicine equipment.

North America has emerged as the leading regional market in, majorly driven by its robust healthcare infrastructure, early adoption of cutting-edge technologies and elevated healthcare expenditure. The United States, particularly, is at the forefront chiefly due to the high prevalence of chronic disorders such cardiovascular diseases and cancer, which accelerate the demand for nuclear imaging significantly. According to the National Cancer Institute, it is estimated that in 2024 total 2,001,140 new cancer cases will be diagnosed in the U.S., and around 611,720 individuals will die from this disease. In addition, government funds for research and development, coupled with the presence of key industry players, further fortifies North America's dominance in the global nuclear medicine equipment market.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the nuclear medicine equipment industry include Biodex Medical Systems Inc. (Mirion Technologies Inc.), Cardinal Health Inc., CMR Naviscan Corporation, DDD-Diagnostic A/S, Digirad Corporation, General Electric Company, Koninklijke Philips N.V., Mediso Ltd., Neusoft Corporation, Siemens AG, SurgicEye GmbH, and Toshiba Corporation.
  • The market is represented by fierce competition among key companies such that are currently emphasizing on strategic acquisitions, partnerships, and product innovation, to sustain their market dominance. For instance, in June 2024, QEII Health Sciences Center of Nova Scotia Health acquired GE Healthcare's StarGuide SPECT/CT equipment. This was a USD 6 million project, co-funded by both Nova Scotia and QEII, and improves diagnostic accuracy for heart diseases and cancer. In addition, technological advancements in radiopharmaceutical development and hybrid imaging systems significantly fuel competition, as key players are actively striving to improve their diagnostic precision and enhance patient outcomes. The competitive landscape is further steered by elevating investments in research and technological innovations, consequently contributing to the optimistic nuclear medicine equipment market outlook.

Key Questions Answered in This Report:

  • How has the global nuclear medicine equipment market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global nuclear medicine equipment market?
  • What is the impact of each driver, restraint, and opportunity on the global nuclear medicine equipment market?
  • What are the key regional markets?
  • Which countries represent the most attractive nuclear medicine equipment market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the nuclear medicine equipment market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the nuclear medicine equipment market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the nuclear medicine equipment market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global nuclear medicine equipment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Nuclear Medicine Equipment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Single-Photon Emission Computed Tomography
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Standalone
      • 6.1.2.2 Hybrid
    • 6.1.3 Market Forecast
  • 6.2 Positron Emission Tomography
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Standalone
      • 6.2.2.2 Hybrid
    • 6.2.3 Market Forecast
  • 6.3 Planar Scintigraphy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Neurology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oncology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cardiology
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Imaging Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Academic and Research Institutes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Biodex Medical Systems Inc. (Mirion Technologies Inc.)
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Cardinal Health Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 CMR Naviscan Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 DDD-Diagnostic A/S
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Digirad Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 General Electric Company
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Koninklijke Philips N.V.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Mediso Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Neusoft Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Siemens AG
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 SurgicEye GmbH
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Toshiba Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Nuclear Medicine Equipment Market: Major Drivers and Challenges
  • Figure 2: Global: Nuclear Medicine Equipment Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Nuclear Medicine Equipment Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Nuclear Medicine Equipment Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Nuclear Medicine Equipment Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Nuclear Medicine Equipment Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Nuclear Medicine Equipment Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Nuclear Medicine Equipment (Single-Photon Emission Computed Tomography) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Nuclear Medicine Equipment (Single-Photon Emission Computed Tomography) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Nuclear Medicine Equipment (Positron Emission Tomography) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Nuclear Medicine Equipment (Positron Emission Tomography) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Nuclear Medicine Equipment (Planar Scintigraphy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Nuclear Medicine Equipment (Planar Scintigraphy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Nuclear Medicine Equipment (Neurology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Nuclear Medicine Equipment (Neurology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Nuclear Medicine Equipment (Oncology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Nuclear Medicine Equipment (Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Nuclear Medicine Equipment (Cardiology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Nuclear Medicine Equipment (Cardiology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Nuclear Medicine Equipment (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Nuclear Medicine Equipment (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Nuclear Medicine Equipment (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Nuclear Medicine Equipment (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Nuclear Medicine Equipment (Imaging Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Nuclear Medicine Equipment (Imaging Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Nuclear Medicine Equipment (Academic and Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Nuclear Medicine Equipment (Academic and Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Nuclear Medicine Equipment (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Nuclear Medicine Equipment (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: North America: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: North America: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: United States: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: United States: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Canada: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Canada: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Asia-Pacific: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Asia-Pacific: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: China: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: China: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Japan: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Japan: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: India: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: India: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: South Korea: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: South Korea: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Australia: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Australia: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Indonesia: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Indonesia: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Others: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Others: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Europe: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Europe: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Germany: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Germany: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: France: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: France: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: United Kingdom: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: United Kingdom: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Italy: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Italy: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Spain: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Spain: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Russia: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Russia: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Latin America: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Latin America: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Brazil: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Brazil: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Mexico: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Mexico: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Middle East and Africa: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Middle East and Africa: Nuclear Medicine Equipment Market: Breakup by Country (in %), 2024
  • Figure 78: Middle East and Africa: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Global: Nuclear Medicine Equipment Industry: SWOT Analysis
  • Figure 80: Global: Nuclear Medicine Equipment Industry: Value Chain Analysis
  • Figure 81: Global: Nuclear Medicine Equipment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Nuclear Medicine Equipment Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Nuclear Medicine Equipment Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Nuclear Medicine Equipment Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Nuclear Medicine Equipment Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Nuclear Medicine Equipment Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Nuclear Medicine Equipment Market: Competitive Structure
  • Table 7: Global: Nuclear Medicine Equipment Market: Key Players